These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29388173)

  • 21. Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland.
    Taipale H; Särkilä H; Tanskanen A; Kurko T; Taiminen T; Tiihonen J; Sund R; Tuulio-Henriksson A; Saastamoinen L; Hietala J
    JAMA Netw Open; 2020 Oct; 3(10):e2019029. PubMed ID: 33119104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild cognitive impairment and anti-Alzheimer disease medications: A cross sectional study of the French National Alzheimer Databank (BNA).
    Tifratene K; Sakarovitch C; Rouis A; Pradier C; Robert P
    J Alzheimers Dis; 2014; 38(3):541-9. PubMed ID: 24018266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.
    Heßmann P; Seeberg G; Reese JP; Dams J; Baum E; Müller MJ; Dodel R; Balzer-Geldsetzer M
    J Alzheimers Dis; 2016; 51(2):545-61. PubMed ID: 26890754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care.
    Lövheim H; Sandman PO; Kallin K; Karlsson S; Gustafson Y
    Int Psychogeriatr; 2006 Dec; 18(4):713-26. PubMed ID: 16879762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
    Wattmo C; Wallin ÅK
    Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of depressive symptoms on health-related quality of life in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease.
    Pusswald G; Moser D; Pflüger M; Gleiss A; Auff E; Stögmann E; Dal-Bianco P; Lehrner J
    Int Psychogeriatr; 2016 Dec; 28(12):2045-2054. PubMed ID: 27576786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NEURODEM: assessment of the iatrogenic alert indicator for nursing home patients with Alzheimer's or Alzheimer-like disease.
    Henni S; Damier FD; Sonnic A; Feinard G; Veyrac G; Pujol JF; de Decker L; Berrut G; Piessard S
    Aging Clin Exp Res; 2016 Oct; 28(5):1015-21. PubMed ID: 26639669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.
    Livingston G; Walker AE; Katona CL; Cooper C
    J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):25-9. PubMed ID: 16801350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway.
    Andersen F; Viitanen M; Halvorsen DS; Straume B; Engstad TA
    BMC Geriatr; 2011 Oct; 11():58. PubMed ID: 21970467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.
    Tolppanen AM; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
    BMJ Open; 2016 Jul; 6(7):e012100. PubMed ID: 27412109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzodiazepine utilization patterns in Alzheimer's disease patients.
    Lagnaoui R; Moore N; Moride Y; Miremont-Salamé G; Bégaud B
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):511-5. PubMed ID: 14513664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study.
    Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study.
    Laitinen ML; Lönnroos E; Bell JS; Lavikainen P; Sulkava R; Hartikainen S
    Int Psychogeriatr; 2015 Apr; 27(4):669-72. PubMed ID: 25412711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subjective cognitive decline is longitudinally associated with lower health-related quality of life.
    Roehr S; Luck T; Pabst A; Bickel H; König HH; Lühmann D; Fuchs A; Wolfsgruber S; Wiese B; Weyerer S; Mösch E; Brettschneider C; Mallon T; Pentzek M; Wagner M; Mamone S; Werle J; Scherer M; Maier W; Jessen F; Riedel-Heller SG;
    Int Psychogeriatr; 2017 Dec; 29(12):1939-1950. PubMed ID: 28737118
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.